# Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/persistence-with-and-adherence-to-fingolimod-compared-with-other-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Niklas Bergvall,Allison Petrilla,Swapna Karkare,Raquel Lahoz,Neetu Agashivala,Ashish Pradhan,Gorana Capkun,Charles Makin,Catherine B. McGuiness,Jonathan R. Korn |
| Citations | 91 |
| DOI | 10.3111/13696998.2014.940422 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.tandfonline.com/doi/pdf/10.3111/13696998.2014.940422?needAccess=true |
| OpenAlex ID | https://openalex.org/W1982508920 |
| PMID | 25019581 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Gorana Capkun](https://scholariq.org/researchers/gorana-capkun/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Sphingolipid Metabolism and Signaling](https://scholariq.org/topics/sphingolipid-metabolism-and-signaling/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.